Whether particular Epstein-Barr virus (EBV) strains are preferentially selected in malignant diseases remains controversial. Assessment of the importance of strain variation in the pathogenicity of EBV has been hampered principally by the lack of accurate data on the prevalence of virus variants in
Sequence variations of Epstein–Barr virus LMP1 gene in nasal NK/T-cell lymphoma
✍ Scribed by Masayoshi Nagamine; Miki Takahara; Kan Kishibe; Toshihiro Nagato; Hideyuki Ishii; Nobuyuki Bandoh; Takeshi Ogino; Yasuaki Harabuchi
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 180 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0920-8569
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Seven strains of Epstein–Barr virus (EBV) are defined based on C‐terminal sequence variations of the latent membrane protein 1 (LMP1). Some strains, especially those with a 30‐bp deletion, are thought to be related to tumorigenic activity and geographical localization. The aims of the s
## Abstract To assess the role of the Epstein‐Barr virus (EBV) latent membrane protein 1 (LMP1) gene in the development of Hodgkin's lymphoma (HL), the polymorphism of this gene in EBV isolates from different geographic locations was analyzed. A 497 bp fragment spanning LMP1 gene exons 1 and 2 was
## Letter to the Editor Primary Epstein-Barr virus-negative nasal-type natural killer/T cell lymphoma of the testis Nasal-type natural killer (NK)/T cell lymphomas involving extranodal presentation such as in the central nervous system (CNS), skin, lung, gastrointestinal (GI) tract, and testis are